Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/13/1101
Active ingredient: Progesterone
Indication: Treatment of moderate and severe traumatic brain injury
Sponsor: BHR Pharma Belgium
287 Avenue Louise/Louizalaan, B-1050 Brussel/Bruxelles, Belgique/België

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/02/2013 Centralised Orphan - Designation EMA/OD/141/12 (2013)802 of 08/02/2013
03/07/2014 Centralised Orphan - Removal of orphan designation from Community Register